How Can Prostatitis Cause Blood in Semen? Inflammation, Hematospermia and Evaluation

Prostatitis can cause blood in semen when infection or inflammation irritates small blood vessels within the prostate or nearby seminal tract, allowing a small amount of blood to mix with ejaculatory fluid. Blood in semen is called hematospermia or haemospermia. Infections and inflammatory conditions are among the most common identifiable causes, but hematospermia does not by itself prove prostatitis, bacterial infection or prostate cancer.

01. How Can Prostatitis Cause Blood in Semen?

Where does blood in semen actually come from?

Semen is not produced by a single organ.

The final ejaculate contains fluid contributed by several parts of the male reproductive tract, particularly:

  • the seminal vesicles;
  • the prostate;
  • the vas deferens and ampullae;
  • the ejaculatory ducts;
  • and the urethral pathway.

Blood entering any part of this pathway can become mixed with seminal fluid and appear during ejaculation.

Why can prostate inflammation cause bleeding?

Inflammation changes the local tissue environment.

Inflamed tissue can develop:

  • increased blood flow;
  • vascular congestion;
  • swelling;
  • fragile superficial capillaries;
  • and irritation around prostate ducts and glandular tissue.

When these small vessels leak, even a very small amount of blood can noticeably discolor semen because normal seminal fluid is pale.

The bleeding does not necessarily indicate a large injury.

How does the blood enter the ejaculate?

During ejaculation, prostate secretions and seminal-vesicle fluid enter the posterior urethra before being expelled through the penis.

If inflammation has produced microscopic bleeding within the prostate or another seminal-tract structure, that blood can mix directly with these secretions.

This can produce:

  • red streaks;
  • pink discoloration;
  • red-brown semen;
  • or darker brown/rust-colored semen as older blood breaks down.

Color alone cannot reliably identify where the bleeding originated.

Detailed sagittal male pelvis showing bladder, seminal vesicle, vas deferens, ejaculatory duct, prostate, urethra and small prostate blood vessels, with microscopic bleeding mixing into seminal fluid. HOW PROSTATE INFLAMMATION CAN LEAD TO BLOOD IN SEMEN Microscopic bleeding from inflamed reproductive tissue can mix with seminal fluid before ejaculation BLADDER SEMINAL VESICLE INFLAMED PROSTATE FRAGILE MICROVESSELS BLOOD MIXES WITH EJACULATE MICROSCOPIC BLEEDING RED BLOOD CELLS enter glandular secretions HEMATOSPERMIA small blood volume can look visually dramatic HEMATOSPERMIA CAN RESULT FROM MICROSCOPIC BLEEDING ANYWHERE ALONG THE SEMINAL TRACT
Mechanism: inflammation can increase vascular congestion and fragility in prostate or seminal-tract tissue. Blood from those small vessels can mix with reproductive secretions before ejaculation, producing visible hematospermia.

Which prostatitis types are most relevant?

The strongest biological relationship is with conditions that actually involve infection or inflammation.

These include:

  • acute bacterial prostatitis, where prostate tissue is actively infected and inflamed;
  • chronic bacterial prostatitis, where persistent or recurrent infection can maintain tissue irritation;
  • and selected inflammatory conditions involving the prostate or adjacent seminal tract.

By contrast, CP/CPPS does not require bacterial infection or visible prostate inflammation.

A man with CP/CPPS can have hematospermia, but blood in semen should not automatically be explained as part of the pain syndrome without considering other causes.

How common is hematospermia?

The true population prevalence is difficult to measure because episodes can be brief, semen is not always inspected and some men do not seek medical attention.

Current EAU sexual-health guidance reports that hematospermia accounts for approximately 1% to 1.5% of urological referrals.

In one large prostate-cancer screening population, hematospermia was reported in approximately 0.5% of participants at study entry.

1–1.5% Approximate proportion of urological referrals represented by hematospermia in EAU-reviewed data.
0.5% Reported at entry in one large prostate-cancer screening cohort; this is not a general-population prevalence estimate.
Usually benign Infections, inflammation and other nonmalignant causes account for most presentations.

02. What Does Blood in Semen Mean—and What Does It Not Prove?

Is a single episode usually dangerous?

In many younger men without additional warning features, a single episode is self-limited and no serious underlying condition is found.

Current EAU guidance states that conservative management is generally the primary approach for men younger than 40 who have a single episode of hematospermia when no concerning clinical features are present.

The 2025 American College of Radiology guidance similarly states that imaging is generally unnecessary for men under 40 with transient hematospermia and no associated signs or symptoms.

Why can the amount of blood look alarming?

A small quantity of blood can produce a dramatic color change when mixed with otherwise pale seminal fluid.

The visual appearance therefore does not reliably measure the volume or severity of bleeding.

Semen may appear:

  • pink;
  • bright red;
  • red-streaked;
  • brown;
  • or rust-colored.

Older blood may become darker as it breaks down.

This color change does not reliably identify the organ responsible.

Is hematospermia the same as blood in urine?

No.

Blood in semen is hematospermia.

Blood in urine is hematuria.

They can occur together, but they arise through different pathways and simultaneous hematuria changes the evaluation because urinary-tract bleeding also needs to be considered.

EAU guidance lists concurrent hematuria among features that can place a patient into a higher-risk hematospermia group.

Can apparent blood in semen come from somewhere else?

Yes.

The first step is sometimes confirming that the blood truly originated within the ejaculate.

EAU guidance notes that apparent hematospermia can occasionally represent:

  • blood originating from the urinary tract;
  • urethral bleeding;
  • or blood from a sexual partner contaminating the sample.

This is sometimes described as pseudo-hematospermia.

Does blood in semen mean prostate cancer?

No.

Most hematospermia is not caused by cancer.

Current EAU guidance states that infections and inflammatory processes account for most cases in which a cause is identified.

However, malignancy becomes more relevant to exclude when hematospermia is:

  • recurrent;
  • persistent;
  • occurring in an older patient;
  • associated with an abnormal prostate examination;
  • associated with other cancer-risk factors;
  • or accompanied by blood in the urine or systemic warning features.

How large is the cancer risk?

There is no single cancer percentage that applies to every man with hematospermia because study populations differ substantially by age and referral pattern.

A systematic review of published hematospermia series reported malignancy in approximately 5.4% of men older than 40 years across the studies that reported this outcome, with prostate cancer accounting for most of those malignancies.

That figure should not be interpreted as the cancer risk for every 40-year-old man with one episode of blood in semen.

Many included patients were referred to urology and therefore represented a more selected population than healthy men in the community.

Does hematospermia mean an STI?

No.

Sexually transmitted infections are one possible infectious cause, but hematospermia alone cannot identify an STI.

Targeted testing becomes more appropriate when there is:

  • new or higher-risk sexual exposure;
  • urethral discharge;
  • dysuria;
  • known partner infection;
  • or another clinical reason to suspect urethral or genital infection.

Does it mean infertility?

No.

Visible blood does not by itself demonstrate:

  • low sperm concentration;
  • abnormal sperm movement;
  • ejaculatory-duct obstruction;
  • or infertility.

Prostate and seminal-tract inflammation can affect semen characteristics in some patients, but fertility is a separate clinical question requiring semen analysis and reproductive evaluation when appropriate.

Urology laboratory illustration showing a semen specimen with blood streaking, microscopy containing red blood cells, urine specimen and comparison between true hematospermia and urinary bleeding. HEMATOSPERMIA — FIRST CONFIRM WHAT IS BLEEDING Blood in semen, blood in urine and external contamination are different clinical observations SEMEN SPECIMEN VISIBLE BLOOD IN EJACULATE = hematospermia Color does not identify the bleeding source. MICROSCOPY RED BLOOD CELLS confirm blood is present, not why it entered semen URINE SAMPLE URINALYSIS / CULTURE hematuria? leukocytes? bacterial growth? HEMATOSPERMIA IS AN OBSERVATION — THE DIAGNOSIS COMES FROM THE CLINICAL CONTEXT Urine testing can identify infection or hematuria; history and examination determine whether prostatitis or another seminal-tract source is plausible.
Blood in semen is a finding, not a final diagnosis: confirming hematospermia is only the first step. Urine testing, infection history, examination and patient risk factors determine whether prostatitis or another urogenital cause is more likely.

03. How Is Blood in Semen Evaluated When Prostatitis Is Suspected?

The evaluation starts with the pattern—not immediately with imaging

A clinician will first clarify:

  • whether blood was truly mixed with semen;
  • whether it happened once or repeatedly;
  • how long the problem has been occurring;
  • the patient’s age;
  • whether ejaculation is painful;
  • whether there are urinary symptoms;
  • whether fever or systemic illness is present;
  • whether blood is also present in urine;
  • whether there has been recent prostate or urinary instrumentation;
  • whether there is STI exposure risk;
  • and whether medicines or systemic bleeding disorders could contribute.

Which associated symptoms point toward prostatitis?

Prostatitis becomes more plausible when hematospermia accompanies:

  • perineal or pelvic pain;
  • painful ejaculation;
  • dysuria;
  • frequency or urgency;
  • difficulty urinating;
  • fever or chills;
  • recurrent urinary infection;
  • or prostate tenderness.

The symptom relationship with ejaculation is explained further in How Can Prostatitis Cause Painful Ejaculation?.

What urine tests are useful?

EAU hematospermia guidance recommends urinalysis, with urine microscopy, culture and susceptibility testing as part of baseline investigation when clinically appropriate.

When bacterial prostatitis is suspected, urine culture becomes particularly important.

A positive culture can:

  • demonstrate bacterial growth;
  • identify the organism;
  • and guide antibiotic treatment.

For the full prostatitis testing process, see How Is Prostatitis Diagnosed?.

When is STI testing appropriate?

Sexual history is part of the evaluation because sexually transmitted infections can contribute to genital-tract inflammation.

Targeted STI testing may be appropriate when there is:

  • a relevant sexual exposure;
  • urethral discharge;
  • urethral burning;
  • known partner infection;
  • or another clinical reason to suspect an STI.

Testing should be selected according to the suspected organism rather than assuming every hematospermia episode represents an STI.

What can the physical examination show?

The evaluation can include:

  • blood pressure measurement;
  • abdominal examination;
  • genital examination;
  • inspection of the urethral opening;
  • and digital rectal examination when appropriate.

A prostate that is markedly tender and swollen in a patient with fever and urinary symptoms supports an acute prostatitis pattern.

A suspicious nodule or other abnormal prostate finding changes the evaluation toward possible prostate malignancy rather than simply assuming inflammation.

Should PSA be measured?

The answer depends on why it is being measured.

Current EAU hematospermia guidance includes PSA testing in appropriately counselled men older than 40 as part of evaluation for underlying prostate disease.

However, active prostatitis can itself elevate PSA.

EAU infection guidance therefore states that PSA should not be used to diagnose prostatitis because it adds no practical diagnostic information during the active episode.

If an acute inflammatory episode is present, PSA interpretation may need to be deferred or repeated after recovery depending on the patient’s age and cancer-risk context.

For that specific issue, see Can Prostatitis Raise PSA?.

Who needs imaging?

Not everyone.

The 2025 American College of Radiology guidance separates patients into different imaging-risk groups.

For a man younger than 40 with transient hematospermia and no associated signs or symptoms, imaging is generally not indicated.

For:

  • men aged 40 or older;
  • persistent hematospermia;
  • recurrent hematospermia;
  • or hematospermia accompanied by concerning symptoms,

pelvic MRI is considered an appropriate initial imaging option, while transrectal ultrasound may also be appropriate in selected cases.

What can MRI evaluate?

MRI can evaluate structures that contribute to semen and ejaculation, including:

  • the prostate;
  • seminal vesicles;
  • ejaculatory ducts;
  • ampullae of the vas deferens;
  • and surrounding pelvic tissues.

It can help identify:

  • cysts;
  • obstruction;
  • hemorrhagic change;
  • structural abnormalities;
  • and suspicious prostate lesions when cancer evaluation is relevant.
Radiology-inspired prostate MRI and transrectal ultrasound panels showing prostate, seminal vesicles and ejaculatory ducts in the evaluation of persistent blood in semen. PERSISTENT HEMATOSPERMIA — TARGETED IMAGING MRI and TRUS can examine prostate and seminal-tract anatomy when the clinical pattern justifies imaging PELVIC MRI axial prostate / seminal-tract view FOCAL CHANGE SEMINAL VESICLES MRI: SOFT-TISSUE ANATOMY + BLOOD PRODUCTS + LESIONS Used selectively according to age, persistence and risk. TRANSRECTAL ULTRASOUND prostate / seminal-vesicle assessment PROSTATE Can assess cysts, calcification, ductal or seminal-vesicle abnormalities IMAGING IS SELECTIVE — A SINGLE LOW-RISK EPISODE DOES NOT AUTOMATICALLY REQUIRE A SCAN Original educational radiology illustration; not an individual patient’s MRI or ultrasound.
Imaging is risk-based: persistent, recurrent or higher-risk hematospermia may justify imaging of the prostate, seminal vesicles and ejaculatory ducts. MRI provides detailed soft-tissue assessment, while TRUS can evaluate selected prostate and seminal-tract abnormalities.

When might cystoscopy be considered?

Cystoscopy is not required for every case.

EAU guidance notes that it may be useful in selected higher-risk or persistent cases, particularly when the urinary tract also needs direct evaluation.

Possible findings include:

  • urethral inflammation;
  • polyps;
  • vascular abnormalities;
  • stones or calcifications;
  • foreign bodies;
  • or other lower urinary-tract lesions.

How does prostate-cancer risk fit into the evaluation?

Hematosp­ermia alone does not diagnose prostate cancer.

Cancer evaluation becomes more relevant when there are independent risk features such as:

  • older age;
  • persistent or recurrent hematospermia;
  • abnormal DRE;
  • concerning PSA after appropriate interpretation;
  • family or inherited prostate-cancer risk;
  • or concurrent hematuria.

The distinction between inflammatory prostate symptoms and cancer evaluation is covered in Prostatitis vs Prostate Cancer.

04. How Is Blood in Semen Treated When Prostatitis Is the Cause?

Treatment targets the underlying condition

There is no medication that should automatically be prescribed simply because semen contains blood.

Treatment depends on why bleeding occurred.

When bacterial prostatitis is responsible, therapy targets the infection.

When no bacterial infection or structural disease is demonstrated, repeated antibiotic courses are not automatically appropriate.

How is bacterial prostatitis treated?

For acute bacterial prostatitis, treatment requires prompt antimicrobial therapy, with more intensive treatment when systemic illness is present.

For chronic bacterial prostatitis, therapy is typically longer and should be guided by microbiological findings when available.

The complete distinction between antibiotics, urinary treatment, pain control and pelvic-floor care is explained in How Is Prostatitis Treated?.

Will the blood disappear when inflammation improves?

Often it does when inflammation or infection was the source.

Blood may remain visible for more than one ejaculation because previously released blood can remain within the seminal tract before being cleared.

A darker brown appearance may reflect older blood rather than continued active bleeding.

However, persistent or repeatedly recurring blood deserves reassessment rather than being indefinitely attributed to an earlier prostatitis episode.

Should antibiotics be prescribed for every episode?

No.

EAU guidance recommends appropriate antibiotics when a urogenital infection or STI has been identified.

Antibiotics should not be used simply because blood is visible in semen if there is no clinical evidence of bacterial infection.

This is particularly important in men with chronic pelvic pain where cultures are repeatedly negative.

What if no cause is found?

This is common.

When appropriate evaluation finds no concerning pathology, reassurance is often the main management.

A systematic review found that spontaneous resolution occurred in the large majority of patients with an unknown cause who were followed without specific treatment.

The goal is to avoid both extremes:

  • ignoring persistent high-risk features;
  • and over-investigating every isolated low-risk episode.

When should blood in semen be medically evaluated?

Evaluation is particularly appropriate when hematospermia is:

  • recurrent;
  • persistent;
  • new in a man aged 40 or older;
  • associated with blood in the urine;
  • associated with fever or chills;
  • associated with significant pelvic, testicular or genital pain;
  • accompanied by difficulty urinating;
  • associated with urethral discharge or STI risk;
  • associated with an abnormal prostate examination;
  • or accompanied by unexplained systemic symptoms.

When is urgent assessment more important?

Blood in semen itself is rarely an emergency.

The surrounding symptoms determine urgency.

Prompt or urgent medical assessment is appropriate for:

  • high fever;
  • shaking chills;
  • confusion;
  • rapidly worsening illness;
  • complete inability to urinate;
  • severe acute scrotal pain or swelling;
  • heavy or persistent blood in the urine;
  • or significant bleeding in a patient with a bleeding disorder or relevant anticoagulant use.

In the prostatitis pathway, fever plus pelvic pain and urinary symptoms raises particular concern for acute bacterial infection.

Clinical pathway separating a single low-risk hematospermia episode from persistent, recurrent or higher-risk blood in semen requiring infection testing, prostate evaluation and selected imaging. BLOOD IN SEMEN — WHEN DOES THE WORKUP EXPAND? Age, recurrence and associated symptoms determine the intensity of evaluation BLOOD SEEN IN SEMEN confirm true hematospermia LOW-RISK, SINGLE TRANSIENT EPISODE WITH NO WARNING FEATURES? YES HISTORY + EXAM reassurance / follow-up NO HIGHER-RISK • age ≥40 • recurrent • persistent • hematuria • symptoms EXPANDED EVALUATION • urine / infection testing • DRE / prostate risk • PSA when appropriate IMAGING IF INDICATED MRI pelvis TRUS in selected cases target structural question TREAT THE CAUSE • bacterial infection • STI • structural/systemic cause THE VISUAL AMOUNT OF BLOOD IS LESS IMPORTANT THAN THE CLINICAL PATTERN One episode in a low-risk younger patient and persistent/recurrent hematospermia with hematuria or abnormal examination belong to different evaluation pathways. Educational pathway; individual testing depends on clinical assessment and local guideline use.
Risk-adapted evaluation: age, recurrence, persistence and associated abnormalities matter more than the dramatic appearance of the semen itself. Higher-risk presentations justify broader laboratory, prostate and imaging evaluation.

What is a realistic outcome?

When infection or inflammation is the cause, the goal is to treat that condition and allow the bleeding source to heal.

When no significant abnormality is found, the goal is often reassurance and appropriate follow-up rather than repeated invasive testing.

When hematospermia keeps recurring, the goal shifts toward identifying whether the bleeding is coming from:

  • the prostate;
  • seminal vesicles;
  • ejaculatory ducts;
  • urethra;
  • urinary tract;
  • or a systemic bleeding condition.

Blood in Semen: What Different Patterns Can Suggest

PatternPossible interpretationUseful next question
Single episode in a younger man with no other symptomsOften benign and self-limiting.Is there recent infection, trauma, procedure or STI risk?
Blood + fever + pelvic pain + dysuriaAcute bacterial prostatitis or another acute urogenital infection becomes important.What do urinalysis, culture and examination show?
Blood + recurrent UTIs + chronic pelvic symptomsChronic bacterial prostatitis may need consideration.Are cultures repeatedly positive or prostate-localizing?
Blood + painful ejaculationProstate, seminal-vesicle or ejaculatory-tract inflammation is possible.Are there urinary or infectious findings?
Blood + negative cultures + chronic pelvic painCP/CPPS may explain the pain but should not automatically explain the bleeding.Is another seminal-tract cause present?
Blood after prostate biopsy or instrumentationIatrogenic hematospermia is common after some procedures.Was the onset temporally related to the procedure?
Persistent or recurrent hematospermiaWarrants more structured evaluation.Would MRI, TRUS or another targeted test answer a specific question?
Blood in semen + blood in urineBoth seminal and urinary sources need consideration.Does the urinary tract also require direct evaluation?
Age ≥40 + recurrent hematospermiaLower threshold for prostate and urogenital malignancy assessment.What do DRE, PSA risk assessment and selected imaging show?

Common Questions About Prostatitis and Blood in Semen

QuestionPractical answer
Can prostatitis cause blood in semen?Yes. Infection and inflammation of the prostate or nearby seminal tract can cause microscopic bleeding that mixes with semen.
What is blood in semen called?Hematospermia or haemospermia.
Does blood in semen mean the prostate is bleeding?Not necessarily. The source can also be the seminal vesicles, ejaculatory ducts, urethra or another urogenital structure.
Can acute bacterial prostatitis cause it?Yes. Acute infection can cause inflamed, vascular prostate tissue.
Can chronic bacterial prostatitis cause it?It can, particularly when recurrent inflammation and infection are present.
Can CP/CPPS cause hematospermia?It can coexist with hematospermia, but CP/CPPS does not require infection or active prostate inflammation, so other causes of bleeding should not automatically be excluded.
Can prostatitis cause red semen?Yes. Fresh blood may produce pink, red or streaked semen.
What does brown semen mean?Brown or rust-colored semen can represent older blood, although color alone cannot identify the cause.
Is one episode usually serious?In a younger man with no warning features, a single transient episode is often benign and self-limited.
Does hematospermia mean cancer?No. Most cases are not caused by cancer.
When does cancer evaluation become more important?With older age, recurrence, persistence, abnormal DRE, concerning PSA interpretation, family risk or concurrent hematuria.
Does blood in semen mean an STI?No. STI is one possible cause and requires targeted testing when exposure or symptoms support it.
Is blood in semen the same as blood in urine?No. Hematospermia and hematuria are different findings.
Can prostatitis cause both?Urinary infection and prostate inflammation can coexist with urinary bleeding, but simultaneous hematuria requires its own evaluation.
Can painful ejaculation and blood in semen occur together?Yes, particularly when prostate or seminal-tract inflammation is present.
Do I need antibiotics?Only when bacterial infection or another antibiotic-responsive infection is clinically supported.
Should semen be cultured?Not routinely as the only test for chronic bacterial prostatitis. EAU guidance favors urine and appropriate localization testing because semen culture alone has limitations.
Should PSA be checked?It may be relevant in appropriately counselled men over 40 or when cancer risk is being assessed, but active prostatitis can raise PSA and PSA should not be used to diagnose prostatitis.
Do I need MRI?Not necessarily. Imaging becomes more appropriate with age ≥40, recurrence, persistence or associated concerning findings.
Is ultrasound useful?TRUS may help evaluate selected prostate, seminal-vesicle, cystic or ductal abnormalities, especially in persistent presentations.
When should I seek urgent care?High fever, chills, confusion, inability to urinate, severe acute scrotal pain or rapidly worsening illness warrants prompt assessment.

Summary

  • Blood in semen is called hematospermia or haemospermia.
  • Prostatitis can cause hematospermia when infection or inflammation affects vascular prostate or seminal-tract tissues.
  • Inflammation can increase local blood flow, swelling and capillary fragility.
  • Small amounts of blood can mix with prostate and seminal-vesicle secretions before ejaculation.
  • Visible hematospermia does not prove that the prostate is the bleeding source.
  • The seminal vesicles, ejaculatory ducts, urethra and other urogenital structures can also contribute blood.
  • Acute bacterial prostatitis is one plausible cause when hematospermia occurs with fever, urinary symptoms and pelvic pain.
  • Chronic bacterial prostatitis can also produce recurrent inflammatory symptoms and hematospermia.
  • CP/CPPS does not require bacterial infection or active prostate inflammation.
  • Blood in semen should not automatically be attributed to CP/CPPS simply because chronic pelvic pain is present.
  • EAU guidance states that infections and inflammatory processes account for most identifiable hematospermia causes.
  • Hematosp­ermia represents approximately 1% to 1.5% of urological referrals in EAU-reviewed data.
  • One prostate-cancer screening cohort reported hematospermia in approximately 0.5% of participants at entry.
  • The true population prevalence remains difficult to determine.
  • A small amount of blood can produce a dramatic visual change in semen.
  • Fresh blood may appear pink or red.
  • Older blood can appear brown or rust-colored.
  • Semen color cannot reliably identify the source or severity of bleeding.
  • Hematosp­ermia is different from hematuria.
  • Concurrent blood in the urine changes the evaluation and can be a higher-risk feature.
  • Apparent hematospermia occasionally comes from urinary bleeding, urethral bleeding or external contamination.
  • A single episode in a low-risk younger man is often self-limited.
  • Current EAU guidance generally favors conservative management for men under 40 with a single uncomplicated episode.
  • Current ACR guidance does not recommend routine imaging for transient uncomplicated hematospermia in men younger than 40.
  • Persistent or recurrent hematospermia deserves more structured evaluation.
  • Age 40 or older lowers the threshold for further investigation.
  • Most hematospermia is not caused by cancer.
  • A published systematic review reported malignancy in approximately 5.4% of men older than 40 across selected hematospermia cohorts, but this should not be interpreted as an individual patient’s risk.
  • Prostate cancer accounted for most malignancies identified in those older referred populations.
  • Cancer risk assessment is particularly relevant when hematospermia recurs, persists or accompanies abnormal prostate findings.
  • Hematosp­ermia does not prove an STI.
  • It does not prove infertility.
  • It does not prove ejaculatory-duct obstruction.
  • History should establish whether the bleeding is single, recurrent or persistent.
  • Painful ejaculation, urinary symptoms, fever, hematuria, sexual exposure and recent procedures help narrow the cause.
  • Urinalysis and urine culture are useful when urinary infection or bacterial prostatitis is suspected.
  • STI testing should be targeted to the exposure and clinical pattern.
  • Blood pressure and systemic bleeding risk can be relevant because hematospermia is not always caused by the prostate.
  • Digital rectal examination can provide information about prostate tenderness or suspicious abnormalities.
  • Prostate massage must not be performed in acute bacterial prostatitis because of bacteremia and sepsis risk.
  • PSA may be relevant to broader prostate-risk assessment in appropriately counselled men over 40.
  • PSA should not be used to diagnose active prostatitis.
  • Active inflammation can temporarily raise PSA and complicate interpretation.
  • For persistent, recurrent or higher-risk hematospermia, MRI can evaluate the prostate, seminal vesicles, ejaculatory ducts and surrounding anatomy.
  • Current 2025 ACR criteria consider pelvic MRI usually appropriate for men aged 40 or older or for persistent, recurrent or symptomatic hematospermia.
  • TRUS may also be useful in selected patients.
  • Cystoscopy is reserved for selected cases in which the urinary tract or urethra needs direct evaluation.
  • Treatment should target the identified cause rather than the appearance of blood itself.
  • Bacterial prostatitis requires infection-directed therapy.
  • Antibiotics should not be automatically prescribed when there is no evidence of bacterial infection.
  • When appropriate evaluation finds no concerning cause, reassurance and follow-up are often sufficient.
  • Blood in semen itself is rarely an emergency, but high fever, inability to urinate, systemic illness or severe acute genital symptoms can make the surrounding condition urgent.

Educational disclaimer: This article provides general medical education about prostatitis and blood in semen. Hematospermia has many possible causes and cannot be attributed to prostatitis, infection, an STI or cancer from appearance alone. Persistent or recurrent blood in semen, age 40 or older, blood in urine, abnormal prostate findings or other concerning symptoms deserve clinical evaluation. High fever, shaking chills, confusion, inability to urinate or rapidly worsening illness may indicate an acute infection or urinary complication requiring prompt medical care.

Explore the Prostatitis Pathway

For the broader distinction between bacterial infection, prostate inflammation and chronic pelvic pain, see Prostatitis and Prostate Pain.

If blood in semen occurs with pain during or after ejaculation, see How Can Prostatitis Cause Painful Ejaculation?.

If fever, dysuria and sudden pelvic pain accompany the bleeding, see Acute Bacterial Prostatitis.

For recurrent culture-proven prostate infection, see Chronic Bacterial Prostatitis.

For urinalysis, urine cultures, prostate examination and localization testing, see How Is Prostatitis Diagnosed?.

For the difference between inflammatory prostate symptoms and malignancy risk, see Prostatitis vs Prostate Cancer.

For why active prostate inflammation can complicate PSA interpretation, see Can Prostatitis Raise PSA?.

Blood in semen also belongs to the broader field of ejaculation and semen health, where seminal-vesicle disease, ejaculatory-duct abnormalities, medications, procedures and other reproductive causes require their own evaluation.

The next guide examines prostate massage in prostatitis, including why massage must be avoided in acute bacterial prostatitis and when localization techniques may be used in selected chronic cases.

Evidence Sources

  1. European Association of Urology. Sexual and Reproductive Health Guidelines — Haemospermia: Causes, Investigation, Risk Stratification and Management.
  2. European Association of Urology. Urological Infections Guidelines — Acute and Chronic Bacterial Prostatitis, Urine Culture, PSA and Prostate Massage.
  3. American College of Radiology. ACR Appropriateness Criteria — Hematospermia, Revised 2025.
  4. Clinical Characteristics, Etiology, Management and Outcome of Hematospermia: A Systematic Review.
  5. Etiologic Classification, Evaluation and Management of Hematospermia.
PreviousHow Can Prostatitis Cause Painful Ejaculation?
NextProstate Massage and Prostatitis: Uses, Risks and When It Should Be Avoided

Related articles

Facebook
Twitter
LinkedIn
WhatsApp
X

Leave a Reply

Your email address will not be published. Required fields are marked *

Written by factbasedurology.

This guide was created by factbasedurology, an educational platform committed to publishing evidence-based insights on men’s sexual wellness. All content is built from credible medical literature and scientific sources, with a focus on synthesizing complex topics into accessible information. We are dedicated to helping men understand their bodies, build confidence, and take informed action

⚠️ This content is for informational purposes only and does not substitute professional medical advice. Always consult a licensed urologist for personal health concerns.

Our goal is to turn clinical knowledge into confidence — with facts you can trust.